Search results for "event"

showing 10 items of 4065 documents

Preventive Analgesia with Pregabalin in Neuropathic Pain from “Failed Back Surgery Syndrome”: Assessment of Sleep Quality and Disability

2015

Objective. Pregabalin group (PGB) is an antiepileptic used to treat neuropathic pain. We evaluated analgesic efficacy and safety for postoperative/chronic pain, disability, and sleep quality in patients who underwent spine surgery administered with PGB, or not, during the presurgical and postsurgical periods. Design. Retrospective cohort study of 60 patients (two groups with 30 patients) with full information on 50 (29 with PGB and 21 without PGB). Ten patients were dismissed as information was lacking. The PGB group (P) (29 patients) received 75 mg/12 hours before surgery, 150 mg 10 hours after surgery, and 150 mg/12 hours 3 days after surgery. The control group (C; 21 patients) took no PG…

medicine.medical_specialtyVisual analogue scalebusiness.industryAnalgesicChronic painPregabalinGeneral Medicinemedicine.diseaseSurgeryPreventive analgesiaOswestry Disability IndexAnesthesiology and Pain MedicineAnesthesiaNeuropathic painmedicineNeurology (clinical)businessAdverse effectmedicine.drugPain Medicine
researchProduct

New frontiers in anticoagulation: non vitamin-K oral anticoagulants in stroke prevention

2016

ABSTRACTIntroduction: Non vitamin-K oral anticoagulants (NOACs) are direct and specific inhibitors of the coagulation factors IIa (dabigatran) and Xa (apixaban, rivaroxaban, edoxaban) which share many pharmacokinetic properties. However, indications are lacking regarding the use of NOACs during thrombolysis, surgery and bleeding events.Areas covered: In this paper, the authors retrospectively analyzed the relevant literature on the NOACs using the PubMed and Google Scholar databases.Expert commentary: Although warfarin is effective in cardioembolic stroke prevention, easier handling and more favorable risk-benefit profile often render NOACs a more preferable therapy choice for neurologists.…

medicine.medical_specialtyVitamin KPyridonesaspirinmedicine.medical_treatmentAdministration Oral030204 cardiovascular system & hematologyDabigatranAnticoagulation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEdoxabanmedicineHumansatrial fibrillationPharmacology (medical)030212 general & internal medicineIntensive care medicineRivaroxabanAspirinbusiness.industryGeneral Neurosciencenon vitamin-K oral anticoagulantWarfarinAnticoagulantsreverse therapyAtrial fibrillationThrombolysismedicine.diseasemeasure of monitoringStrokewarfarinchemistryAnesthesiaPyrazolesApixabanstroke preventionNeurology (clinical)businessmedicine.drugExpert Review of Neurotherapeutics
researchProduct

Antivitamin K Drugs in Stroke Prevention

2014

Among the different subtypes of ischaemic strokes, almost 20 % are of cardiac origin. Different are the causes of cardioembolic stroke, but the most common is the atrial fibrillation, a supraventricular arrhythmia. Appropriate use of antiplatelet drugs and anticoagulants after transient ischaemic attack (TIA) or ischaemic stroke depends on whether the underlying cause is cardioembolic or of presumed arterial origin. Adequate antiplatelet therapy is recommended for secondary prevention after cerebral ischaemia of presumed arterial origin, whether for patients with TIA and ischaemic stroke of cardiac origin, mainly due to atrial fibrillation. Vitamin K antagonists (VKAs) are highly effective …

medicine.medical_specialtyVitamin KSettore MED/09 - Medicina InternaAppropriate useInternal medicinemedicineAnimalsHumanscardiovascular diseasesRandomized Controlled Trials as TopicPharmacologySupraventricular arrhythmiabusiness.industryPatient choiceStandard treatmentAnticoagulantsVKAs Stroke preventionAtrial fibrillationmedicine.diseaseStrokeIschemic Attack TransientStroke preventionCardiologyCerebral ischaemiaCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsDiscovery and development of direct thrombin inhibitorsCurrent Vascular Pharmacology
researchProduct

Residual vein thrombosis and D-dimer for optimizing duration of anticoagulation in idiopathic deep vein thrombosis.

2010

Long-term anticoagulant treatment is highly effective in preventing recurrent Venous Thrombo-Embolism (VTE) in patients with idiopathic Deep Vein Thrombosis (DVT) of the lower limbs, though associated with an increased risk for major bleeding that may offset the benefits of anticoagulation. Accordingly to recent guidelines, patients with idiopathic DVT should be treated for at least 3 months and then should be evaluated for the risk-benefit ratio of long-term therapy. However, such ‘time for decision’ is often unclear and the optimal duration of VKA remains debatable. In recent studies, markers for the assessment of the individual risk for recurrent thrombosis have been proposed, which can …

medicine.medical_specialtyVitamin Kmedicine.drug_classDeep veinDrug Administration ScheduleFibrin Fibrinogen Degradation ProductsRisk FactorsNeoplasmsDrug DiscoveryD-dimerSecondary PreventionHumansMedicineUltrasonographyVenous ThrombosisPharmacologyFirst episodebusiness.industryVascular diseaseAnticoagulantAnticoagulantsresidual vein thrombosis anticoagulant therapymedicine.diseaseThrombosisSurgeryVein thrombosisVenous thrombosismedicine.anatomical_structurebusiness
researchProduct

THE ATHEROGENIC LIPOPROTEIN PHENOTYPE AS PREDICTOR OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON-CORONARY FORMS OF ATHEROSCLEROSIS

2008

medicine.medical_specialtyatherogenic lipoproteins cardiovascular events atherosclerosisbusiness.industryInternal medicineInternal MedicinemedicineCardiologyIn patientGeneral MedicineAtherogenic lipoprotein phenotypeCardiology and Cardiovascular MedicinebusinessAtherosclerosis Supplements
researchProduct

An mHealth App for Supporting Quitters to Manage Cigarette Cravings With Short Bouts of Physical Activity: A Randomized Pilot Feasibility and Accepta…

2016

BackgroundWhile gains in reducing smoking rates in Finland have been made, prevalence rates are still substantial. Relapse rates among smokers engaged in quit-smoking programs are high. Physical activity has been proposed as one means to help smokers manage cravings. Software and apps on mobile phone and handheld devices offer an opportunity to communicate messages on how to use physical activity to manage cravings as part of quit-smoking programs. ObjectiveWe aimed to test the feasibility, acceptability, usability, and preliminary efficacy of an mHealth mobile phone app, Physical activity over Smoking (PhoS), to assist smokers in quitting smoking in a randomized controlled trial. The app w…

medicine.medical_specialtybehavior change020205 medical informaticsmedia_common.quotation_subjectphysical activityHealth Informatics02 engineering and technologyInformation technologyliikuntaRelapse preventionsmokinglaw.invention03 medical and health sciencesphysical training0302 clinical medicineRandomized controlled triallawtupakointikäyttäytymismallitIntervention (counseling)mental disorders0202 electrical engineering electronic engineering information engineeringmedicinemobiilisovellukset030212 general & internal medicineta315mHealthrelapse preventionmedia_commonmobile appsOriginal Paperbusiness.industrywithdrawalPublic healthBehavior changebehavioural patternsUsabilityta3141ta3142vieroitusAbstinenceT58.5-58.64mHealth appmHealthrandomized controlled trialPhysical therapyPublic aspects of medicineRA1-1270businessJMIR Mhealth Uhealth
researchProduct

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration fi…

2016

BACKGROUND Salivary α-amylase (sAA) activity alternations are observed in major depressive disorder (MDD) being associated with depression severity and its specific psychopathological dimensions with anxiety being attributed to distress. No data is available on sAA in MDD according to Hamilton Rating Scale for Depression (HAMD-17) and State-Trait Anxiety Inventory (STAI). The exploratory study examines whether and to what extent baseline sAA level is interrelated to the psychopathological features including severity of symptoms and specific psychopathological dimensions. MATERIAL AND METHODS The basal, non-stimulated sAA activity was studied in 20 non-late-life adult, treatment-naive MDD pa…

medicine.medical_specialtybehavioral disciplines and activities03 medical and health sciences0302 clinical medicinemental disordersmedicinePsychiatryGeneral DentistryFirst episodebusiness.industryResearchHamilton Rating Scale for Depressionmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Community and Preventive Dentistry030227 psychiatryDrug-naïveDistressstomatognathic diseasesUNESCO::CIENCIAS MÉDICASMajor depressive disorderAnxietymedicine.symptombusiness030217 neurology & neurosurgeryState-Trait Anxiety Inventorymedicine.drugPsychopathologyJournal of clinical and experimental dentistry
researchProduct

Eating Disorders in Male and Female Athletes

2013

medicine.medical_specialtybiologybusiness.industryAthletesPrevalencePhysical activitymedicine.diseasebiology.organism_classificationEating disordersEpidemiologyMedicineHealth educationDisease preventionbusinessPsychiatry
researchProduct

Technique and safety aspects of resistance exercises: a systematic review of the literature.

2009

A systematic review of the scientific literature was conducted to identify the optimal ranges of motion for preventing injury in the main joints of the body during resistance exercise performance. These ranges of motion are independent of the type in which the resistance exercises could be applied (ie, adults, elderly, athletes, recreational exercisers), and the regions examined include the shoulder, spine, and knee, which are injured most often. It can be concluded that during the performance of any resistance exercise, it is possible to put anatomical structures at risk with certain body positions; therefore, it is necessary to understand these movements so injury can be avoided.

medicine.medical_specialtybiologybusiness.industryAthletesStrength trainingPoison controlPhysical Therapy Sports Therapy and RehabilitationResistance TrainingScientific literaturebiology.organism_classificationMotion (physics)Occupational safety and healthPhysical medicine and rehabilitationInjury preventionPhysical therapyMedicineHumansWounds and InjuriesOrthopedics and Sports MedicineRange of Motion ArticularbusinessRange of motionThe Physician and sportsmedicine
researchProduct

Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes

2011

Type 2 diabetes is associated with a cluster of inter-related plasma lipid and lipoprotein abnormalities, including reduced HDL-C, a predominance of small, dense LDL and elevated triglycerides. These abnormalities occur even in prediabetes, before blood sugars rise sufficiently in order to confirm a diagnosis of diabetes, and this transition phase incurs important cardiovascular risk. This is the rationale for paying attention to dyslipidemia through the use of the hypolipidemic, rather than hypoglycemic drugs only. A literature search (by Medline and Scopus) was performed. The authors also manually reviewed the references of selected articles for any pertinent material. Beyond the ‘quantit…

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismInsulinmedicine.medical_treatmentType 2 diabetesmedicine.diseaseMetformindiabetes LDL size prevention small dense LDL therapyEndocrinologyInternal medicineDiabetes mellitusmedicinelipids (amino acids peptides and proteins)PrediabetesCardiology and Cardiovascular MedicinebusinessPioglitazoneDyslipidemiamedicine.drugLipoproteinClinical Lipidology
researchProduct